HIV-1 resistance genotyping by ultra-deep sequencing and 6-month virological response to first-line treatment.
Stéphanie RaymondNicolas JeanneFlorence NicotChloé DimeglioRomain CarcenacAgnès HarterNoémie RangerGuillaume Martin-BlondelPierre DelobelJacques IzopetPublished in: The Journal of antimicrobial chemotherapy (2022)
The Vela UDS platform is appropriate for determining antiretroviral resistance in patients on a first-line antiretroviral treatment. Further studies are needed on the use of UDS for therapeutic management.
Keyphrases
- hiv infected
- antiretroviral therapy
- hiv positive
- human immunodeficiency virus
- hiv aids
- hiv infected patients
- end stage renal disease
- newly diagnosed
- high throughput
- chronic kidney disease
- ejection fraction
- men who have sex with men
- peritoneal dialysis
- prognostic factors
- hepatitis c virus
- hiv testing
- south africa
- high resolution
- genome wide
- mass spectrometry